198 related articles for article (PubMed ID: 6737643)
1. High-density-lipoprotein cholesterol in bodybuilders v powerlifters. Negative effects of androgen use.
Hurley BF; Seals DR; Hagberg JM; Goldberg AC; Ostrove SM; Holloszy JO; Wiest WG; Goldberg AP
JAMA; 1984 Jul; 252(4):507-13. PubMed ID: 6737643
[TBL] [Abstract][Full Text] [Related]
2. Testosterone, sex hormone-binding globulin, lipoproteins, and vascular disease risk.
Dickerman RD; McConathy WJ; Zachariah NY
J Cardiovasc Risk; 1997; 4(5-6):363-6. PubMed ID: 9865668
[TBL] [Abstract][Full Text] [Related]
3. Changes in lipid and lipoprotein levels after weight training.
Goldberg L; Elliot DL; Schutz RW; Kloster FE
JAMA; 1984 Jul; 252(4):504-6. PubMed ID: 6737642
[TBL] [Abstract][Full Text] [Related]
4. Serum lipoprotein responses during active and stable weight reduction in reproductive obese females.
Friedman CI; Falko JM; Patel ST; Kim MH; Newman HA; Barrows H
J Clin Endocrinol Metab; 1982 Aug; 55(2):258-62. PubMed ID: 7085852
[TBL] [Abstract][Full Text] [Related]
5. Lipoprotein analysis in bodybuilders.
McKillop G; Ballantyne D
Int J Cardiol; 1987 Dec; 17(3):281-8. PubMed ID: 3679608
[TBL] [Abstract][Full Text] [Related]
6. The effects of menopause and training on serum lipids.
Rainville S; Vaccaro P
Int J Sports Med; 1984 Jun; 5(3):137-41. PubMed ID: 6746176
[TBL] [Abstract][Full Text] [Related]
7. Impaired vasoreactivity in bodybuilders using androgenic anabolic steroids.
Lane HA; Grace F; Smith JC; Morris K; Cockcroft J; Scanlon MF; Davies JS
Eur J Clin Invest; 2006 Jul; 36(7):483-8. PubMed ID: 16796605
[TBL] [Abstract][Full Text] [Related]
8. Dietary influences on cardiovascular disease risk in anabolic steroid-using and nonusing bodybuilders.
Kleiner SM; Calabrese LH; Fiedler KM; Naito HK; Skibinski CI
J Am Coll Nutr; 1989 Apr; 8(2):109-19. PubMed ID: 2708728
[TBL] [Abstract][Full Text] [Related]
9. Serum lipids in power athletes self-administering testosterone and anabolic steroids.
Alén M; Rahkila P; Marniemi J
Int J Sports Med; 1985 Jun; 6(3):139-44. PubMed ID: 4030188
[TBL] [Abstract][Full Text] [Related]
10. Androgens reduce HDL2-cholesterol and increase hepatic triglyceride lipase activity.
Kantor MA; Bianchini A; Bernier D; Sady SP; Thompson PD
Med Sci Sports Exerc; 1985 Aug; 17(4):462-5. PubMed ID: 4033402
[TBL] [Abstract][Full Text] [Related]
11. Blood chemistry of current and previous anabolic steroid users.
O'Connor JS; Baldini FD; Skinner JS; Einstein M
Mil Med; 1990 Feb; 155(2):72-5. PubMed ID: 2106655
[TBL] [Abstract][Full Text] [Related]
12. Relationship of menopausal status and exercise level to HDL-cholesterol in women.
Harting GH; Moore CE; Mitchell R; Kappus CM
Exp Aging Res; 1984; 10(1):13-8. PubMed ID: 6734681
[TBL] [Abstract][Full Text] [Related]
13. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.
Oida K; Nakai T; Tamai T; Kutsumi Y; Kobayashi T; Hayashi T; Yamada S; Takeda R
Artery; 1982; 10(4):266-85. PubMed ID: 7181672
[TBL] [Abstract][Full Text] [Related]
14. Increases in dietary cholesterol and fat raise levels of apoprotein E-containing lipoproteins in the plasma of man.
Cole TG; Patsch W; Kuisk I; Gonen B; Schonfeld G
J Clin Endocrinol Metab; 1983 Jun; 56(6):1108-15. PubMed ID: 6841553
[TBL] [Abstract][Full Text] [Related]
15. Evolution of serum lipids in two male bodybuilders using anabolic steroids.
Lajarin F; Zaragoza R; Tovar I; Martinez-Hernandez P
Clin Chem; 1996 Jun; 42(6 Pt 1):970-2. PubMed ID: 8665691
[TBL] [Abstract][Full Text] [Related]
16. Severe depression of high-density lipoprotein cholesterol levels in weight lifters and body builders by self-administered exogenous testosterone and anabolic-androgenic steroids.
Webb OL; Laskarzewski PM; Glueck CJ
Metabolism; 1984 Nov; 33(11):971-5. PubMed ID: 6493049
[TBL] [Abstract][Full Text] [Related]
17. Elevated plasma low-density lipoprotein and high-density lipoprotein cholesterol levels in amenorrheic athletes: effects of endogenous hormone status and nutrient intake.
Friday KE; Drinkwater BL; Bruemmer B; Chesnut C; Chait A
J Clin Endocrinol Metab; 1993 Dec; 77(6):1605-9. PubMed ID: 8263148
[TBL] [Abstract][Full Text] [Related]
18. Reversibility of the effects on blood cells, lipids, liver function and hormones in former anabolic-androgenic steroid abusers.
Urhausen A; Torsten A; Wilfried K
J Steroid Biochem Mol Biol; 2003 Feb; 84(2-3):369-75. PubMed ID: 12711025
[TBL] [Abstract][Full Text] [Related]
19. Elevated high-density lipoprotein cholesterol levels in older endurance athletes.
Seals DR; Allen WK; Hurley BF; Dalsky GP; Ehsani AA; Hagberg JM
Am J Cardiol; 1984 Aug; 54(3):390-3. PubMed ID: 6465022
[TBL] [Abstract][Full Text] [Related]
20. Effects of nicotinic acid therapy on plasma lipoproteins and very low density lipoprotein apoprotein C subspecies in hyperlipoproteinemia.
Yovos JG; Patel ST; Falko JM; Newman HA; Hill DS
J Clin Endocrinol Metab; 1982 Jun; 54(6):1210-5. PubMed ID: 7076797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
